These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 491237)
21. Vasopressin-resistant nephrogenic diabetes insipidus. A result of amphotericin B therapy. Barbour GL; Straub KD; O'Neal BL; Leatherman JW Arch Intern Med; 1979 Jan; 139(1):86-8. PubMed ID: 760689 [TBL] [Abstract][Full Text] [Related]
22. [Mechanism of change in the concentrating and natriuretic ability of the kidneys in experimental tetanus]. Mikhaĭlov VV; Chesnokova NP Patol Fiziol Eksp Ter; 1968; 12(1):48-51. PubMed ID: 5742895 [No Abstract] [Full Text] [Related]
23. [DDAVP loading test (a test on kidney concentrating ability)]. Shimizu K Nihon Rinsho; 1979 Jun; Suppl():2519-20. PubMed ID: 491203 [No Abstract] [Full Text] [Related]
25. Studies on kidney function in subjects exposed to organic solvents. II. The effect of desmopressin in a concentration test and the effect of exposure to organic solvents on renal concentrating ability. Askergren A; Allgën LG; Bergström J Acta Med Scand; 1981; 209(6):485-8. PubMed ID: 7257866 [TBL] [Abstract][Full Text] [Related]
26. [Kidney concentrating ability in children and adolescents with normal kidneys]. Janda J; Bláhova K; Marek V; Eliásek J Kinderarztl Prax; 1988 Mar; 56(3):133-7. PubMed ID: 3398393 [No Abstract] [Full Text] [Related]
27. [Maximal kidney concentrating ability in patients with renal artery stenosis]. Nádvorníková H; Stríbrná J; Schück O; Firt P; Hahn M; Zvolánková K Vnitr Lek; 1975 Oct; 21(10):937-47. PubMed ID: 1189304 [No Abstract] [Full Text] [Related]
28. Hypertonicity and TonEBP promote development of the renal concentrating system. Kültz D Am J Physiol Renal Physiol; 2004 Nov; 287(5):F876-7. PubMed ID: 15475542 [No Abstract] [Full Text] [Related]
29. Urinary concentrating mechanism and Aquaporin-2 abundance in rats chronically treated with aluminum lactate. Mahieu S; Millen N; Contini Mdel C; Gonzalez M; Molinas SM; Elías MM Toxicology; 2006 Jun; 223(3):209-18. PubMed ID: 16675087 [TBL] [Abstract][Full Text] [Related]
30. Changes in the concentrating capacity of the kidney in patient with primary aldosteronism in relation to treatment. Barcáková J; Horký K; Pacovský V Rev Czech Med; 1976; 22(3):134-8. PubMed ID: 968139 [No Abstract] [Full Text] [Related]
31. [Problem of the mechanism of decrease in maximal kidney concentrating ability in aged]. Nádvorníková H Cas Lek Cesk; 1971 Dec; 110(50):1171-5. PubMed ID: 5133543 [No Abstract] [Full Text] [Related]
32. [Concentrating ability of the kidney in patients with chronic glomerulonephritis at a stage with normal glomerular filtration values]. Nádvorniková H; Schück O; Rossman P Vnitr Lek; 1984 Feb; 30(2):125-33. PubMed ID: 6719849 [No Abstract] [Full Text] [Related]
33. [Kidney concentrating function in renal denervation and pharmacological effects]. Pirŭova B Eksp Med Morfol; 1988; 27(2):50-5. PubMed ID: 3168909 [No Abstract] [Full Text] [Related]
34. [Urine concentrating ability test with the vasopressin analog DDAVP]. Aurell M; Delin K; Ewald J Lakartidningen; 1979 May; 76(21):2045-6. PubMed ID: 449481 [No Abstract] [Full Text] [Related]
35. [Methods and usefulness of renal function determinations in children with particular reference to the ability of urine dilution and concentration]. Szczepski O; Maciejewski J; Bittner K Pediatr Pol; 1975 Jan; 50(1):101-6. PubMed ID: 1089234 [No Abstract] [Full Text] [Related]
37. [DDAVP in the treatment of hypophyseal diabetes, nocturnal enuresis and in rapid determination of the concentrating function of the kidney]. Likhardus V; Nemetova V; Legotska V Sov Med; 1976 Oct; (10):106-9. PubMed ID: 1023360 [No Abstract] [Full Text] [Related]